novartis ag u s approves patch to treat alzheimers swiss drug maker novartis ag received food and drug administration approval for its exelon skin patch to treat alzheimers disease novartis said this was the first approval world wide for the patch which is for patients with mild to moderate alzheimers exelon had sales of &# million last year swiss bank vontobel said it expects sales to rise to around &# million but warned of competition from pfizer inc s aricept and the market entry of forest laboratories inc s namenda 
